F. ŞERMET Et Al. , "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy," Journal of Medical Cases , vol.3, no.4, pp.250-253, 2012
ŞERMET, F. Et Al. 2012. Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy. Journal of Medical Cases , vol.3, no.4 , 250-253.
ŞERMET, F., ÖZMERT, E., DEMİREL, S., & SÜREN, E., (2012). Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy. Journal of Medical Cases , vol.3, no.4, 250-253.
ŞERMET, FİGEN Et Al. "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy," Journal of Medical Cases , vol.3, no.4, 250-253, 2012
ŞERMET, FİGEN Et Al. "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy." Journal of Medical Cases , vol.3, no.4, pp.250-253, 2012
ŞERMET, F. Et Al. (2012) . "Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy." Journal of Medical Cases , vol.3, no.4, pp.250-253.
@article{article, author={FİGEN ŞERMET Et Al. }, title={Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Best s Vitelliform Macular Dystrophy}, journal={Journal of Medical Cases}, year=2012, pages={250-253} }